Diphtheria-tetanus-acellular Pertussis Vaccines

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2010-08-05
Clinical Trial Update: Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. [Phase 3]
Phase 3 trial evaluating Boostrix vaccine versus Decavac for tetanus and acellular pertussis; completed with results posted in 2010.